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Changes in the activities of ornithine decarboxylase 
(ODe) and aryl hydrocarbon hydroxylase (AHH) were 
investigated in rat epidermis after wounding the skin 
and application of 7,12-dimethylbenz(a)anthracene 
(DMBA), 2,3,7 ,8-tetrachlorodibenzo-p-dioxin (TCDD), 
and several enzyme inhibitors. Wounding of the skin by 
vigorous shaving led to a marked induction of ODC 
activity with a peak at 6 hr. Topical application of a 
single dose of tetradecanoylphorbol-13-acetate to 
wounded skin did not affect the activities of ODC and 
AHH. Application of a single large dose (2.5 mg) of 
DMBA increased AHH activity 7-fold without affecting 
ODC activity. DL-a-difluoromethyl ornithine, a specific 
irreversible inhibitor of ODC, almost completely abol-
ished ODC activity but did not inhibit DMBA- or TCDD-
induced AHH activity. Several potential modifiers, in-
cluding retinoic acid, indomethacin, 1,3-diamino-2-pro-
pranol, O'-naphthoflavone, and SKF 525 A had inequal 
effects on ODC and AHH activities. These data indicate 
that ODC and AHH induction processes in the epidermis 
are independent biochemical events that are not causally 
related. 
Ornithine decarboxylase (ODe, Ee 4.1.1.17) is the rate-lim-
iting enzyme in the biosynthesis of the polyamines putrescine, 
spermidine, and spermine. Several lines of evidence indicate 
that the polyamines play an important role in normal and 
neoplastic cellular growth (reviewed in references 1,2). Marked 
increases in epidermal ODC activity can be detected after 
topical appHcation of certain carcinogens or tumor promoting 
agents, such as 7,12-dimethylbenz(a)anthracene (DMBA) and 
tetradecanoylphorbol-13-acetate (TPA) on mouse skin [3], or 
after mechanical wounding of the skin [4,5]. The ability of 
different compounds to induce epidermal ODC activity corre-
lates well with their tumor promoting activity, and it has been 
proposed that ODe induction is required for tumor promotion 
to occur in the 2-stage carcinogenesis model [3]. Aryl hycirocal'-
bon hydroxylase (AHH, 1.14.14.2) is a cytochrome P-450-
dependent microsomal monooxygenase complex, which is re-
sponsible for the metabolic conversion of polycyclic aromatic 
hydrocarbons to their active, caTcinogenic forms (reviewed in 
reference 6). Experimental evidence indicates that in response 
to microsomal enzyme-inducing compounds, elevated ODe ac-
tivity and microsomal enzyme induction form a tight temporal 
sequence [7-10]. ODe induction has been suggested to repre-
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sent an early event during the sequence of subcellular changes 
between the time that the inducer first enters the cell and the 
time when induced xenobiotic-metabolizing enzyme activities 
become maximal [11]. 
Since epidermis is most likely the target tissue for DMBA 
and the site where DMBA is activated to ultimate carcinogenic 
form(s) [12], we decided to study the interrelationship between 
induced ODe and AHH activities in wounded rat epidermis 
treated with DMBA and several enzyme inhibitors. Data are 
presented suggesting that these enzymes are induced and in-
hibited independent of each other in this experimental system. 
MATERIALS AND METHODS 
Materials 
Four-week-o ld male Wistar rats (70- 100 g) were housed in plastic 
cages in a room with a 12-I"tr Light cycle from 06:00 to 18:00 and 
contro lled temperature and humidity. Water and standru'd peUeted rat 
diet were provided ad libitum. DMBA, tv-naphthoflavone and trans-
retinoic acid were plU'chased from Sigma Chemical Company (St Louis, 
MO, USA); TPA from Consolidated Midland Corp. (Brewster , NY, 
USA); SKF-525 A from Smith, Kline a nd French Labs (Philadelph ia, 
PA, USA) ; Indomethacin from Fru'mos (Turku, Finla nd) ; 1,3-diamino-
2-propanol from F luka AG (Buchs, Switzerland); DL-(l- "'C)ornithine 
(specific activi ty 58 mCi/mmol), CO"-mMet and PCS (Phase Combin-
ing System) were from The Radiochemical Centre (Amersham, Eng-
land). DL-a-ditluoromethyl ornithine (DFMO) was a generous gift from 
Dr D. J. Wilkins (Centre de Recherche Men eLl International, Stras-
bourg, France) . 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was kindly 
given to US by Dr D. W. Nebert (NIH, Bethesda, MD). AU other 
reagents w('re of the highest grade commerciaUy available. 
Treatment of the Animals 
The rats were shaved under ligh t ether anesthesia with an electr ic 
clipper on the dorsal area. The remaining hair was vigorously shaved 
off with a regula r electric razor (B raun Sixtant S, Bra un AG, Frankfurt, 
FRG). Th is treatment removed the superficia l keratinized layer and 
produced multiple abrasions in the skin. DMBA, TCDD, TPA, and 
other compounds (dissolved in acetone or methanol) were applied to 
the skin in a volume of 1.0 ml immediately after shaving. 6 or 24 hr 
a fter treatment, the rats were killed by decapitation, the skins were cut 
off and placed in ice-cold 0.1 M phosphate-buffered saline, pH 7.4 . To 
avoid variations due to diurna l rhythms, the ra ts were kill ed between 
14:00 and 15:00. Epidermis and dermis were sepru'ated by immersion in 
water at 55°C for 30 sec as described [13]. After reimmeJ'sion in ice-
cold buffer the skin was placed on a plate and the epidermis was 
scraped off with a surgical scapel. 
ANN and ODe A ssay 
The epidermis was homogenized with a Potter-Elvehjem glass-glass 
homogenizer in 1.5 ml of 100 mM Tris-HCl buffer, pH 7.1, conta in ing 1 
mM EDTA, 0.5 mM dithiothreitol, 0.5 mM pyridoxa l phospha te and 0.1 
mM L-ornithine. Lru'ger pru-ticles were centrifuged down at ::1,000 rpm 
for 5 min, and the supernatant fraction was stored at - 40°C for no 
more than 24 hI'. 
AHH was routinely assayed in the epidermal extracts by the fluori -
metric method of Nebert and Gelboin [14]. Duplicate samples were 
a lways assayed. One unit is defined as the amount of enzyme cata lyzing 
in 1 min the formation of hydroxylated products causing fluorescence 
equivalent to that of 1.0 pmol of the 3-hydroxybenzo(a) pyrene standard. 
Specific activity denotes units per mg of soluble protein. 
Following centrifugation at 30,000 X g for 30 min, the soluble epi-
dermal extracts were assayed in duplicate for ODC activity by meas-
Ul'ing the release of '''CO" from DL-(l- '''C)ornithine essentially as 
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described by Beaven, Wilcox, and T erpsta [15). 100 J.tl-aliquots of the 
supernatant nuid plus 0.45 J.tCi of DL-(l-" 'C)ornithine were incubated 
for 30 min at 37°C in eppendorf vials placed inside a liquid scint illation 
via l. The reaction was stopped by adding 250 J.tl of 50% trichloroacetic 
acid (TCA) , and the '''C0 2 resulting from the reaction was a bsorbed by 
a piece of filter paper impregnated with 100 J.tl of CO2-mMet-ethylen-
glycol (1:1). After addition of 7 ml of PCS-xylene scin tillation cocktail 
the radioactivity was measW'ed in a LKB-Wallac liquid scint illation 
counter (Wallac, Turku, Finland). One uni t of enzyme activity was 
defined as the amount catalyzing the release of 1 nmol of CO2 per 30 
min under the standaJ'd assay condit ions. The specific activity was 
defined as activity units per mg of protein. 
Protein content was determined for each sample by the method of 
Lowry et aI [16], after precipi tation of prote in by 25% TCA, centrifu-
gation and further washing with TCA to avoid interference by dithio-
threitol [17]. Statistics were performed using a 2-tailed Student i-test, 
and resul ts are expressed as means ± SD. 
RESULTS 
Effect of Wounding and Application of DMBA and TPA on 
Rat Epidermal OeDe and AHH Activities 
As seen in Fig 1, ODC activity increased fro m a low control 
value at zero Ill' to a sharp peak (16-fold greater than that of 
con trol at 6 hr) and returned to the basal level by 48 hl' after 
treatment. Similru' rapid increase a nd decrease in ODC activity 
h as been observed after wounding rat skin by punch biopsies 
[4], or ha i.r plucking [18]. A single topical applciation of 100 
Ilmol ofTPA induced ODC activity slightly above control levels, 
and DMBA (2.5 mg) treatment slightly r educed ODC activity. 
However, t hese differences in induced ODC activities were not 
s tatistically significant. The peak level ofODC activi ty OCCUlTed 
at 6 hI' after wounding or treatment of wounded skin with TP A. 
The inabili ty of TP A to induce ODC activity more significantly 
m ay be attributed to the intense induction caused by wounding 
alone, which may be enough to cover the induction by TP A. 
Fig 2 shows the response of epidermal AHH to application of 
DMBA or TP A. Basal AHH activi ty steadily decreased during 
wound hea ling, the activity at 48 hI' after tr eatment being a bout 
25% of the value at zero time. DMBA produced a marked 
induction of AHH activity, tne maximum (about 7-fold) occur-
ring at 24 h.r. Application of TP A did not have any appru'ent 
effect on AHH activity. 
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FI G 1. Changes in ODC activity in wounded rat epidermis after 
applica tion of OMBA or TPA. Groups of 3 rats were treated with 2.5 
mg of DMBA or 100 J.tmol of TPA in l.0 ml acetone immediately after 
shaving the hair of the animals as described in "Materials and Meth-
ods." Two control rats received acetone only. T he rats were killed at 
the times indicated a nd the activity of ODC was measured in the 
epidermal extracts. (0--0), cont rols; ( _____ ), OMBA-treated; 
(0---0), TPA-treated rats. ODC specific aclivity denotes units/mg 
protein . Coefficients of vaJ'iation ranged from 0.05 to 0.58. 
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FIG 2. Changes in the activity of AHH in wounded rat epidermis 
after application of DMBA or TPA. The rats were treated as described 
in Fig 1. Duplicate assays of AHH activity were done in epidermal 
extracts obtained from 3 treated a nd 2 control an imals killed at indi-
cated t ime-points. AHH specific activity denotes units/ mg protein. 
(0--0), controls; ( _____ ), OMBA-treated; (0---0), TPA-treated. 
Coefficients of variation ranged from 0.04 to 0.55. 
TA BLE T. Effect of DFMO on ODe and AHH activities in woun ded 
rat epidermis trea.ted with DMBA or TeDD 
Control 
OMBA 2.5 mg 
OMBA + DFMO 100 J.tmol 
T CDD 1.0llg 
TCOD + DFMO 100 J.tmol 
ODe acLivity 
Un its/mg 
prolein 
2.89 ± 1.67 
2,59 ± 0.88 
0.02 ± 0.03" 
2.27 ± 1.68 
0.02 ± 0.03 " 
AHH activi ty 
Units/ mg 
protein 
6.27 ± 5.56 
45.18 ± 12.03 
47.12 ± 11.62 NS 
146.24 ± 38.13 
217.79 ± 119.74 NS 
The rats were wounded by vigorous shaving on the dorsal aJ·ea. 
OMBA, T CDD and DFMO were applied on the skin immediately after 
shaving. 24 hI' later the rats were killed and the activit ies of ODC and 
AHH were assayed in the epidermal extracts as described in "Materials 
and Methods." Each value represents the mean ± SO of 6 rats. 
"Significantly different compru'ed to OMBA-treated value (p < 
0.001), 
" Significantly different compaJ'ed to TCDD-treated value (p < 0.01). 
NS = not significant. 
Effect of DFMO on ODe and AHH Activities in Wounded 
Rat Epidermis 
DFMO is a specific, enzyme-activated, irreversible inhibitor 
of ODC [19,20]. Table I shows the effect of a single topical 
application of 100 Ilmol of DFMO on rat epidermal ODC and 
AHH activities 24 ill' after treating th e animals with DMBA or 
T CDD. On a molar basis, the capacity of TCDD to induce 
AHH activity is much greater t ha n t hat of any other agent 
tested [21-23]. Application of 2.5 mg of DMBA on the skin led 
to a 7-fold increase in AHH activity without any significant 
effect on induced ODC activity. Simultaneous application of 
100 Ilmol of DFMO virtually completely abolished ODC activity 
«1% of control) , but t he corresponding AHH activity was 
unaffected . TCDD induced AHH activity 23-fold but had no 
appru'ent effect on ODC activity. Again, administration of 
DFMO resulted in a complete inhibi t ion of ODC activity, 
whereas AHH activity was not significantly affected. This 
means that in spite of specific suppression of ODC activity, the 
AHH induction process was continued normally. 
Effect of Different Inhibitors on ODe and AHH Activities 
Several agents were tested for t heir ability to inhibit ODC 
and AHH activities in rat epidermi (Table II), Inhibitors of 
microsomal monooxygenase system, a-naph thoflavone and 
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TABLE II. Effect of different inhibitors on ODC and AHH activitie!; 
(i h,. " 24 hr 
ODC" (%)' AHH" (%) ODC (%) AHH (%) 
Control 6.95 ± 1.65 (Ill) 10.78 ± 5.06 (43) 3.24 ± 1.65 (13) 
DMBA 2.5 mg 6.27 ± 1.39 (l00) 25.26 ± 9.83 (100) 3.00 ± 0.79 
+ Retinoic acid 100 f.lmol 0.33 ± 0.22111111 (5) 29.45 ± 12.47 NS (117) 0.78 ± 0.18111111 
(108) 
(100) 
(26) 
(180) 
(149) 
(39) 
5.86 ± 4.61 
45.19 ± 11.37 
36.35 ± 3.57 NS 
32.31 ± 14.08 NS 
35.70 ± 12.20 NS 
40.35 ± 11.73 NS 
44.00 ± 20.85 NS 
(l00) 
(80) 
(71) 
(79) 
(89) 
(97) 
+ Indomethacin 100 Ilmol 4.29 ± 0.85" (68) 7.22 ± 4.33"" (29) 5.41 ± 3.3] NS 
+ Oiaminopropanol 100 f.lmol 0.94 ± 0.36"'1" (15) 18.16 ± 4.46 NS (72) 4.48 ± 0.721' 
+ a-Naphthoflavone 10 f.lmol 2.32 ± 0.901'1"1 (37) 19.77 ± 6.34 NS (78) 1.16 ± 0.671'1' 
+ SKF 525 A 100 Ilmol 2.29 ± 1.08"" (37) 7.49 ± 5.951' (30) 2.44 ± 1.45 NS (81) 
" Time-points after treatment. 
"The numbers are means ± SO of 4 rats. The activities are expressed in units/mg protein. 
' Numbers in parenthesis denote percentage of OMBA-treated value. 
'1'111 S ignificantly dirferent compared to OMBA-treated value (p < 0.001), ~'I (p < 0.01),'1 (p < 0.05), NS = not significant. 
SKF 525 A, both inhibited ODe activity by about 73% at 6 h.l" 
after treatment. SKF 525 A inhibited AHH activity by 70% at 
6 ill, whereas a-naphthoflavone did not affect AHH activity 
significantly. Retinoic acid strongly inhibited induction of ODe 
activity, but did not affect AHH induction by DMBA. Indo-
methacin inhibited ODe activity by 32% and AHH activity by 
71% at 6 ill. By 24 hI', the activities of AHH and ODe had 
returned to near DMBA-treated value. Diaminopropanol also 
efficiently inhibited ODe activity (85% inhibition at 6 ill) 
without producing significant changes in the activity of AHH. 
Apparently these data do not indicate any close parallelism 
between induced ODe and AHH activities. 
DISCUSSION 
There is evidence for the existence of a specific cytosolic 
receptor for induction of AHH, and this receptor provides also 
high affinity binding of TeDD [23,24]. Oka and N ebert [25] 
postulated that ODe a nd AHH activities are induced via the 
same cytosolic receptor. The strict temporal relationship be-
tween induced ODe and AHH activities in many experiments 
[7-11] supports this theory. 
However, at least with respect to epidermis, our present data 
do not support this hypothesis. The present study showed a 
remarkable increase in ODe activity in rat epidermis after 
wounding, the maximal activity being observed after 6 hr. 
Application of a large dose of TPA (100 Mmol) did not affect 
ODC activity significa ntly. Lesiewicz, Morrison, and Goldsmith 
(18) have shown that rat epidermal ODe responds to the 
application of TP A in a similar manner to that seen in the 
mouse system [3] , and that hair plucking and application of 
TP A stimulate ODC by different mechanisms. It is evident that 
the rapid and intense increase in ODe activity elicited by the 
vigorous shaving technique used in this work was sufficient to 
mas~ th~ ODC-inducing effect of TPA. Wounding the skin or 
ap~li~atlOn of TP A produced no significant changes in AHH 
actIvIty, although there was a slight decrease in basal AHH 
activities during wound healing. 
Experiments with the highly selective, irreversible inhibitor 
of ODC, i.e. , DFMO, clearly showed a dissociation between 
ODe and AHB induction processes. When administered topi-
cally immediately after shaving and application of DMBA or 
TeDD, DFMO almost totally abolished ODe activity in the 
epidermis. The dramatic decrease in ODC activity did not 
suppress AHB expression in epidermal cells. Although the 
increases in ODe and ABH activities were produced by differ-
ent kinds of stimuli (mechanica l and chemical), it is evident 
that the ABB induction process does not need a pre-existing 
induction in ODC activity. Clinical trials of DFMO for several 
proliferative diseases have begun [26]. Conceivably, DFMO also 
offers a highly useful tool when assessing the role of ODC 
induction in tumor promotion in different tissues, including the 
skin. 
Retinoids (vitamin A analogs) have been shown to reduce the 
effects of carcinogens and to inhibit growth of neoplastic cells 
[27]. However, the protective effect of retinoids against carci-
nogenesis is not universal [28,29]. Retinoic acid (RA) has been 
reported to inhibit TPA-induced ODC activity in mouse skin 
[30,31]. Retinoids also reduce the formation of active interm e-
diates of benzo(a)pyrene bound to DNA in cul tures of human 
fibroblasts, not by a direct inhibition of benzo(a)pyrene-metab-
olizing enzymes, but by a preferential inhibition of the de novo 
synthesis of these enzymes [32]. When applied on wounded rat 
skin concomitantly with DMBA, RA markedly inhibited ODe 
activity, but did not have any significant effect on induced 
AHB activity. The failu.l"e of RA to inhibit AHH activity may 
in part explain the lack of protective effect of retinoids on 
chemical-induced carcinogenesis in some cases [28,29,33]. 
Indomethacin, a prostaglandin synthesis inhibitor, was not 
very effective in reducing ODe induction in rat skin, in contrast 
to its remarkable inhibiting activity on TPA-induced ODe 
activity in mouse skin [34,35]. This may be explained in terms 
of species differences and different kinds of stimuli used to 
induce ODe activity (chemical vs. mechanical) [18]. Indometh-
acin had a marked inhibiting effect on AHH activity at 6 Iu-
after treatment. This is consistent with the finding that indo-
methacin inhibits formation of mutagenic metabolites from 
benzo(a)pYI'ene [36]. 
1,3-Diamino-l-propanol in an efficient inhibitor of hepatic 
ODe activity [37]. When applied on rat skin, diaminopropanol 
had a marked reducing effect on epidermal ODe induction, but 
did not affect ABB induction significantly. The synthetic tJa-
vone derivative a-naphthoflavone, which is an inhibitor of 
ABH, significantly suppresses skin tumor production by 
DMBA in mice [38]. When applied on rat skin, L~-naphthotJa­
vone reduced ODe induction without affecting AHB signifi-
cantly. The ability of a-naphthoflavone to inhibit epidermal 
ODe activity has also been reported in DMBA-treated mice 
[28]. 
The data presented are consistent with om previous obser-
vations in cultmed cells suggesting a dissociation between ODe 
and ARH activities [39]. In both systems, a virtually complete 
disappearance of ODe activity by specific inhibitors has no 
effect on polycyclic aromatic hydrocarbon-induced ABB activ-
ity. Also several potential modifiers have unequal effects on 
ODe and ABB activities. Therefore we conclude that the ABB 
induction process in mammalian cells can be expressed without 
previous enhancement in ODe activity. 
We thank Ms Hitva Saarikoski ror expert technical assistance. 
REFERENCES 
1. J iinne J, Poso H, Raina A: Polyamines in rapid growth and cancer. 
Biochim Biophys Acta 473:241-293,1978 
2. Heby 0: Role of polyamines in the control of cell proliferation and 
differentiation . Differentiation 19:1-20, 1981 
3. O'Bl'ien TG: The induction of ornithine decat'boxylase as an eat'ly, 
possibly obligatory event in mouse skin carcinogenesis. Cancer 
Res 36:2644-2653, 1976 
4. Mizutani A, Inoue H , Takeda Y: Changes in polyamine metabolism 
during wound healing in rat skin. B iochim Biophys Acta 338:183-
190, 1974 
5. Clark-Lewis I, Murray A W: Tumor promotion and the induction of 
Oct. 1982 
epiderma l ornithine decarboxylase activity in mechanically stim-
ulated mouse skin. Cancer Res 38:494-497, 1978 
6. Gelboin HV: Benzo(a)pyrene metabolism, activation, and carcino-
genesis: role and regulation of mixed-function oxidases and re-
lated enzymes. Physiol Rev 60:1107-1166,1980 
7. Costa M, Costa ER, Manen C-A, S ipes IG , RusseU DH: Adenosine 
cycl ic 3',5' -monophosphate-dependent protein kinase and orni-
thine decarboxylase involvement in the induction of cytochrome 
P-450 and hepatic hyper trophy. Mol P harmacoI12:871-878, 1976 
8. Byus CV, Costa M, Sipes IG, Brodie BB, RusseU DH: Activation of 
3',5'-cyclic AMP-dependent protein kinase and induction of or-
ni thine decarboxylase as eru'ly events in induction of mixed-
funct ion oxygenases. Proc Natl Acad Sci 73:1241-1245, 1976 
9. Russell DH, Byus CV, Manen C-A: Proposed model of major 
sequent ial biochemical events of a trophic response. Life Sci 
19: 1297- 1306,1976 
10. Manen C-A, Costa M, Sipes IG, Russell DH: FUJ'ther evidence of 
cycl ic AMP-mediated hyper trophy as a prerequisite of drug-
specific enzyme induction. Biochem Pharmacol 27:219-224, 1978 
11. Nebert DW, Jensen NM, Perry JW, Oka T: Association between 
ornithine decarboxylase induction and the Ah locus in mice 
treated with polycyclic aromatic compounds. J Bioi Chem 
255:6836-6842, 1980 
12. D iGiovanni, Jachau MR: Biotransformation a nd bioactivation of 
7,12-dimethylbenz(a)ant lu'acene (7,12-DMBA). Drug Metab Rev 
11:61-102, 1980 
13. Morrison OM, Goldsmith LA: Orn ithine decru'boxylase in rat skin. 
J Invest Dermatol 70:309-313, 1978 
14. Nebert DW, Gelboin HV: Substrate-inducible microsomal aryl 
hydroxylase in mammalian cell culture. J Bioi Chern 243:6242-
6249, 1968. 
15. Beaven MA, Wilcox G, Terpsta GK: A microprocedW'e for the 
measurement of "'CO. release from ('4C)carboxyl-labeled amino 
acids. Anal Biochem 84:638-641, 1978 
16. Lowry OH, Rosebrough NJ , Fan AL, Randall RJ: Protein mea-
surement with the Folin phenol reagent. J Bioi Chern 193:265-
275, 1951 
17. Bennet 1'1': Membrane filtration for determining protein in the 
presence of interfering substances. NatW'e 213:1131-1132, 1967 
18. Lesiewicz J, Morrison DM, Goldsmith LA: Ornithine decarboxylase 
in rat skin: 2. differential response to hair plucking and a tumor 
promoter. J Invest Dermatol 75:411- 416, 1980 
19. Metcalf BW, Bey P, Danzin C, Jung MJ, Casru'a P, Vevert JP: 
Catalytic irreversible inhibition of mammalian ornithine decru'-
boxylase (EC 4.1.1.17) by substrate and product analogues, J 
Amer Chern Soc 100:2551-2553, 1978 
20. Seiler N, Danzin C, Prakash NJ , Koch-Weser J: Enzyme-activated 
Irreversible Inhibitors. Edited by N Seiler , MJ Jung, J Koch-
Weser. Amsterdam, Elsevier-North Holland Biomedical Press, 
1978, pp 55-71 
21. Poland A, Glover E: Compal'ison of 2,3,7,8-tetrachlorodibenzo-p-
dioxin, a potent inducer of ary l hydrocaJ'bon hydl'oxylase, with 3-
methylcholanthl·ene. Mol Pharmacol 10:349-359, 1974 
22. Hook GER, Hasema n JK, Lucier GW: Induction and suppression 
of hepatic and extrahepatic microsomal fore ign-compound me-
tabolizing enzyme systems by 2,3,7,8-tetrachlorodibenzo-p-
dioxin. Chern Bioi Interact 10:199-214, 1975 
23. Poland A, Glover E,. Kende AS: Stereospecific, high affinity binding 
of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. J Bioi 
ODe AND AHH IN RAT EPIDERMIS 249 
Chem 251:4936-4946, 1976 
24. Guenther TM, Nebert DW: Cytosolic receptor for aryl hydJ'ocarbon 
hydJ'oxlase induction by polycyclic aJ'omatic compounds. J Bioi 
Chem 252:8981-8989, 1977 
25. Nebert DW, Oka T: Association of rapid large increases in ornithine 
decaJ'boxylase activity with the Ah locus in mice treated with 
polycyclic aromatic compounds, Proc X Int Congr Biochem 1976, 
p 386 
26. Sjoesderma A: Suicide enzyme inhibitors as potential drugs. CUn 
Pharmacol Ther 30:3-22, 1981 
27. Sporn MB, Dunlop NM, Newton DL, S mi t h JM: Prevention of 
chemical caJ'c inogenesis by vitamin A a nd its synthetic analogs 
(retinoids), Fed Proc 35:1332-1338, 1976 
28. Verma AK, Conrad EA, Boutwell RK: Induction of mouse epider-
mal orni thine decaJ'boxylase activity and skin tumors by 7,12-
dimethylbenz(a)anthl'acene-modulation by retinoic acid and 7,8-
benzoflavone. CaJ'cinogenesis 1:607-611, 1980 
29. Dickens MS and Sorof S: Retinoid prevents transformation of 
cultured mammaJ'y glands by procarcinogens but not by many 
activated caJ·cinogens. NatW'e 285:581-584, 1980 
30. Verma AK, Boutwell RK: Vitamin A acid (retinoic acid), a potent 
inhibitor of 12-0-tetradecanoylphorbol-13-acetate-induced orni-
thine decarboxylase activity in mouse epidermis. Cancer Res 
37:2196-2201, 1977 
31. Verma AI<, Rice HM, Shapas BG, Boutwell RK: Inhibition of 12-
0-tetradecanoylphorbol-13-acetate-induced ornithine decarbox-
ylase activity in mouse epidermis by vitamin A analogs (reti-
noids). Cancer Res 38:793-801, 1978 
32. Kohl F-V, Rudiger HW: Tumor prevention by vitamin A: In vitro 
studies with human cultW'ed fibroblasts. J Cancer Res Clin Oncol 
93:149-160, 1979 
33. Nettesheim 1', Williams ML: The influence of vitamin A on the 
susceptibi.lity of the rat lung to 3-methylcholantlu·ene. Int J 
Cancel' 17:351-357, 1976 
34. Verma AK, Rice HM, Boutwell RK: Prostaglandins and tumor 
promot.ion: inhibition of tumor promoter-induced ornithine de-
caJ'boxylase activity in epidermis by inhibi tors of prostaglandin 
synthesis. Biochem Biophys Res Commun 79:1160-1166, 1977 
35, Verma AK, Ashendel CL, Boutwell RK: Inhibition of prostaglandin 
synthesis inhibitors of the induction of epidermal ornithine de-
caJ'boxylase activity, the accumulation of prostaglandins, and 
tumor promotion caused by 12-0-tetradecanoylphorbol-13-ace-
tate. Cancer Res 40:308-315, 1980 
36, MaJ'nett LJ, Reed GA, Dennison DJ: Prostaglandin synthetase 
dependent activation of 7,8-dihydJ'0-7,8-dihydroxy-benzo(a)-py-
rene to mutagenic derivatives, Biochem Biophys Res Commun 
82:210-216, 1978 
37. Piik K, Poso H, Jiinne J: Reversible inhibi tion of rat Uver regen-
eration by 1,3-diamino-2-propanol, an inhibitor of ornithine de-
carboxylase. FEBS Lett 89:307-312, 1978 
38. Kinoshita N, Gelboin HV: AJ'yl hydrocaJ'bon hydJ'oxylase and poly-
cyclic hydJ'ocarbon tumorigenesis: Effect of the enzyme inhibitor 
7,8-benzoflavone on tumorigenesis and macromoleculaJ' binding. 
Proc Natl Acad Sci USA 69:824-828, 1972 
39, Raunio H, Skurnik M, Korhonen P , Pelkonen 0: Dissociation 
between ornithine decaJ'boxylase activity and aJ'y l hydrocaJ'bon 
hydroxylase induction in cell cultW'es treated with 
benz(a)antlu'ucene and inhibi tors of ornithine decarboxylase. 
Biochem Pharmacol, 31:189-193, 1982 
